Cargando…
PARP Inhibitors and Proteins Interacting with SLX4
SIMPLE SUMMARY: The aim of this review is to highlight recent work performed on the activity of a class of cancer drugs (PARP inhibitor) in various cell lines, either expressing or not expressing proteins interacting with the DNA repair protein SLX4. This could be at the basis of the development of...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913592/ https://www.ncbi.nlm.nih.gov/pubmed/36765954 http://dx.doi.org/10.3390/cancers15030997 |